Authors

• Jeff S. Healey (ORCID: https://orcid.org/0000-0003-1216-7580)
• Qi Pauls (ORCID: https://orcid.org/0000-0002-6612-698X)
• David Tirschwell (ORCID: https://orcid.org/0000-0002-8059-2901)
• Pamela Plummer
• Richard A. Kronmal (ORCID: https://orcid.org/0000-0002-9897-7076)
• Marco R. Di Tullio (ORCID: https://orcid.org/0000-0002-3031-4196)
• Elsayed Z. Soliman (ORCID: https://orcid.org/0000-0001-5632-8150)
• Fadi B. Nahab (ORCID: https://orcid.org/0000-0003-1710-9881)
• Hooman Kamel (ORCID: https://orcid.org/0000-0002-5745-0307)
• Rebeca Aragón García (ORCID: https://orcid.org/0009-0009-4258-8539)
• Joseph P. Broderick (ORCID: https://orcid.org/0000-0002-7323-7709)
• WT Longstreth
• Mitchell S Elkind
• L. Scott Janis
• Jordan J. Elm

Institutions

• National Institutes of Health (US)
• Emory University (US)
• Medical University of South Carolina (US)
• University of Washington (US)
• Cornell University (US)
• Emory University Hospital (US)
• Population Health Research Institute (CA)
• MIND Research Institute (US)
• Cancer Research And Biostatistics (US)
• National Institute of Neurological Disorders and Stroke (US)
• University of Washington Applied Physics Laboratory (US)
• Weill Cornell Medicine (US)
• Wake Forest University (US)
• Columbia University (US)
• University of Cincinnati Medical Center (US)
• McMaster University (CA)

Publication Details

Journal

European Stroke Journal

Published

2024-08-30

DOI

https://doi.org/10.1177/23969873241276358

Citations

6

Primary Topic

Atrial Fibrillation Management and Outcomes

Type

article

Field-Weighted Citation Impact

2.41

Funders

• Bristol-Myers Squibb
• Pfizer
• Roche Diagnostics
• National Institute of Neurological Disorders and Stroke